Accuray

U.S. medical device company Accuray Inc. (NASDAQ: ARAY) has announced that it has received market approval from Chinese regulatory authorities for its Accuray Precision Treatment Planning System (TPS). This approval will enable the integration of the TPS with the Tomo C radiation therapy system, which is part of the CNNC-Array…